Dysmenorrhea
📧 Sign up to get email alerts when something new happens for Dysmenorrhea.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2013-03-15Clinical Trial Update: A Randomized, Sham Device Controlled, Single Blinded Trial of Portable Transcutaneous Electrical Nerve Stimulation and Heat Therapy Machine in Women With Dysmenorrhea [Phase 3]
Phase 3 randomized, sham-controlled trial evaluating a portable transcutaneous electrical nerve stimulation and heat therapy device for dysm…
-
CLINICAL_TRIALS trial_result · 2013-03-07Clinical Trial Update: Randomized Controlled Trial of Acupuncture for Dysmenorrhea [Phase 3]
A Phase 3 randomized controlled trial evaluating acupuncture for dysmenorrhea has completed, sponsored by National Taiwan University Hospita…
-
FDA approval · 2013-02-07FDA Approved: ALEVE GELCAPS — Supplemental Application (Bayer HealthCare LLC.)
FDA approved a supplemental application to add Aleve GelCaps (naproxen sodium) as a new dosage form for the Aleve product line, expanding th…
-
CLINICAL_TRIALS trial_result · 2013-02-01Clinical Trial Update: Effectiveness of Nanoone Woman Underwear Using in the Management of Dysmenorrhea [NA]
A completed clinical trial evaluating the effectiveness of Nanoone Woman Underwear for managing dysmenorrhea; results were posted in 2013.
-
CLINICAL_TRIALS trial_result · 2012-12-27Clinical Trial Update: The Effect of Transcutaneous Electric Nerve Stimulation on Primary Dysmenorrhea-a Randomized Control Study [Phase 1, Phase 2]
A randomized phase 1/2 trial evaluated the effect of transcutaneous electrical nerve stimulation on primary dysmenorrhea; the study has comp…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2012-10-25Clinical Trial Update: Treatment of Endometriosis With Norethindrone Acetate ( NA) VS. Gonadotropin- Releasing Hormone (GnRH) Agonist (Lupron Depot 11.25 mg) [Phase 3]
Phase 3 clinical trial comparing norethindrone acetate to leuprolide acetate (Lupron) for treatment of endometriosis and related dysmenorrhe…
-
CLINICAL_TRIALS trial_result · 2012-09-24Clinical Trial Update: Dose-Finding Study of PDC31 in Patients With Primary Dysmenorrhea [Phase 1]
The document reports the completion of a Phase 1 dose-finding study of PDC31 in patients with primary dysmenorrhea.
-
FDA approval · 2012-06-13FDA Approved: NAPROXEN SODIUM — Supplemental Application (Bionpharma Inc.)
FDA approved a supplemental application for Naproxen Sodium from Bionpharma Inc., updating the product's regulatory approval.
-
CLINICAL_TRIALS trial_result · 2012-05-25Clinical Trial Update: A Study to Evaluate the Efficacy of Seasonique for the Treatment of Cyclic Pelvic Pain [Phase 2]
Phase 2 trial evaluating Seasonique for cyclic pelvic pain in dysmenorrhea; the study is completed and results were posted in 2012.
-
CLINICAL_TRIALS trial_result · 2012-04-20Clinical Trial Update: A Pilot Study of Acupoint Injection for Primary Dysmenorrhea [NA]
This report notes the completion of a pilot clinical trial evaluating acupoint injection for primary dysmenorrhea. The study assessed whethe…
-
FDA approval · 2012-03-15FDA Approved: ALEVE GELCAPS — Supplemental Application (Bayer HealthCare LLC.)
FDA approved a supplemental application to add Aleve GelCaps containing naproxen sodium, expanding the approval to include a new dosage form…
-
CLINICAL_TRIALS trial_result · 2012-02-27Clinical Trial Update: Effect on Primary Dysmenorrhea [Phase 3]
A Phase 3 trial sponsored by Bayer assessing treatment for primary dysmenorrhea has completed and posted results (as of February 27, 2012).
-
FDA approval · 2011-11-08FDA Approved: NAPROXEN — Original Application (Aurobindo Pharma Limited)
The FDA approved Aurobindo Pharma Limited's original application for a generic naproxen product. Naproxen is a nonsteroidal anti-inflammator…
-
CLINICAL_TRIALS trial_result · 2011-10-19Clinical Trial Update: Effectiveness of the Transcutaneous Electrical Nerve Stimulation in Dysmenorrhea [NA]
A completed clinical trial update assessing the effectiveness of transcutaneous electrical nerve stimulation (TENS) for treating dysmenorrhe…
-
FDA approval · 2011-09-19FDA Approved: NAPROXEN — Original Application (Cipla USA Inc.)
FDA approves Cipla USA Inc.'s Naproxen under Original Application, making a generic naproxen product available. It is used to relieve pain a…
-
FDA approval · 2011-08-24FDA Approved: NAPROXEN — Original Application (Exelan Pharmaceuticals, Inc.)
The FDA approved Exelan Pharmaceuticals' original ANDA for Naproxen (generic naproxen). This confirms a generic naproxen product for arthrit…
-
FDA approval · 2011-07-22FDA Approved: MEFENAMIC ACID — Original Application (Lupin Pharmaceuticals, Inc.)
The FDA approved Lupin Pharmaceuticals' original ANDA for mefenamic acid, allowing a generic version of this NSAID to enter the market.
-
CLINICAL_TRIALS trial_result · 2011-07-06Clinical Trial Update: Efficacy and Safety Study of Lidocaine Vaginal Gel for Recurrent Dysmenorrhea (Painful Periods) [Phase 2]
This is a Phase 2 clinical trial update reporting completion and posted results of a study evaluating lidocaine vaginal gel for recurrent dy…
-
CLINICAL_TRIALS research · 2011-06-23Clinical Trial Update: Psychological Outcomes From a Study of Acupuncture Treatment on Experimentally Primary Dysmenorrhea [Phase 3]
A Phase 3 clinical trial update evaluating acupuncture for primary dysmenorrhea and reporting psychological outcomes.
-
FDA approval · 2011-04-12FDA Approved: INDOMETHACIN — Original Application (XLCare Pharmaceuticals Inc.)
FDA approved the Indomethacin Original Application for XLCare Pharmaceuticals Inc., enabling a generic indomethacin product to reach the mar…
-
CLINICAL_TRIALS trial_result · 2011-04-06Clinical Trial Update: Pertubation With Lignocaine in Endometriosis [Phase 2]
Phase 2 clinical trial of lignocaine perturbation in endometriosis has completed, with assessment also addressing dysmenorrhea.
-
CLINICAL_TRIALS trial_result · 2011-03-02Clinical Trial Update: The Effectiveness of Lng IUD for Treatment of the Patient Undergone Conservative Surgery for Pelvic Endometriosis [Phase 3]
Phase 3 trial assessing the effectiveness of the levonorgestrel-releasing intrauterine system (LNG-IUS) for endometriosis-related pelvic pai…
-
CLINICAL_TRIALS trial_result · 2011-02-10Clinical Trial Update: Long Term Outcomes Following Total Laparoscopic Hysterectomy and Laparoscopic Supracervical Hysterectomy [NA]
An update on long-term outcomes from a clinical trial comparing total laparoscopic hysterectomy and laparoscopic supracervical hysterectomy …
-
FDA approval · 2010-12-10FDA Approved: IBUPROFEN — Original Application (Dolgencorp, Inc.)
FDA approved Dolgencorp, Inc.'s ibuprofen 200 mg tablets as an original generic application (ANDA). The approval supports OTC use for relief…
-
FDA approval · 2010-12-01FDA Approved: DICLOFENAC SODIUM — Original Application (Rising Pharma Holdings, Inc.)
FDA approved the original ANDA for Diclofenac Sodium (generic diclofenac) from Rising Pharma Holdings, Inc., providing a generic diclofenac …